MTOR and cancer: Furthermore, we now show that the concomitant inhibition of mTOR and MEK promotes the apoptotic demise of HNSCC cells specifically in tumors expressing the PIK3CA oncogene, the most frequently driver mutation in this cancer type [8, 12].